Sanofi
SNY
Jodie situation report
Sanofi's current read is isolated; its market group is not confirming.
No new filing conclusion is available. 0 of 15 group members are active now; 0 filing-linked outsiders are moving with the group, and 0 of 25 directly disclosed connections are confirming.
- SNY's market-adjusted activity becomes unusual and at least one connected name confirms.
Invalidation: The isolated read changes if SNY's group or a disclosed connection begins moving with it.
Who this business touches
The relationships behind SNY
Customers, suppliers, partners and competitors named in company filings—not inferred from headlines.
Depended on by
DNLIDenali Therapeutics Inc. Common StockpartnerMay 7, 2026 ▾
“For programs covered by collaboration agreements (including those with Takeda, Sanofi, and Biogen), we expect to commercialize only in certain geographies, as defined by the terms of the agreements with the counterpart, and rely on our partners to provide com…”
Filing peers
No filing peers are available for this name yet.
Open the three relationships above to see Jodie’s filing proof. Pro unlocks 24 more links, every receipt, and alerts when connected names begin moving. Unlock the full network →
What is moving around it
Live connections
SNY is currently a Follower in the organic co-movement group Drug Manufacturers - General. This group is discovered from market behaviour rather than assigned from an industry taxonomy. 1 filing-linked name are in the relationship map; none is currently confirmed as moving with the group.